
Fluconazole
A single 150 mg dose of fluconazole cleared vaginal yeast infections as well as 7 days of vaginal clotrimazole, weekly doses kept recurrent infections away in 90.8% of women at 6 months, and daily doses cut serious fungal infections after bone marrow transplant. Its interactions come mainly from slowing liver enzymes: warfarin is the most serious one on this page, and grapefruit and yeast probiotics are the food and supplement points.
Prescription medication: not a dietary supplement
This is an FDA-approved (or investigational) drug, not a supplement. It requires a prescription and medical supervision. The information below summarizes clinical-trial evidence for education only. It is not a recommendation to obtain or use it without a doctor.
Quick decision guide
May help most
Adults and children with yeast infections or cryptococcal meningitis, and people having a bone marrow transplant, treated by a prescriber
Common dosing range
Set by your prescriber. For a vaginal yeast infection the label dose is one 150 mg tablet; for other infections the label gives a first-day loading dose of twice the daily dose, then 100 to 400 mg once daily depending on the infection
When to expect effects
Symptoms of mouth and throat thrush usually improve within several days, but the label says to continue for at least 2 weeks; recurrent vaginal infection prevention was studied over 6 months
Watch out for
It raises levels of many medicines, including warfarin (bleeding has been reported), sulfonylurea diabetes pills (one fatal low blood sugar with glyburide) and CYP3A4 statins; rare serious liver injury and QT prolongation; avoid in pregnancy except for severe infections
What is it
Fluconazole is a prescription azole antifungal sold as Diflucan and as generic tablets, oral suspension and an intravenous solution. The label approves it for vaginal yeast infections (usually a single 150 mg tablet), yeast infections of the mouth, throat and esophagus, cryptococcal meningitis, and prevention of yeast infections in people having a bone marrow transplant. Unlike oral ketoconazole tablets, it has no boxed warning, but it still interacts with many medicines because it slows several liver enzymes.
Is it worth it for you?
Use this as a quick fit check, not a diagnosis.
Worth considering if…
Probably skip if…
Evidence at a glance
| Goal | Effect | Best fit | Time |
|---|---|---|---|
vaginal yeast infection (single dose) Good Evidence | Similar to 7 days of vaginal clotrimazole; about 3 in 4 clinically cured at 35 days | Adults with an acute, uncomplicated vaginal yeast infection | Assessed at 14 and 35 days |
preventing recurrent vaginal yeast infections (maintenance) Good Evidence | Large during treatment (90.8% versus 35.9% disease-free at 6 months), smaller after stopping | Women with recurrent vulvovaginal candidiasis | During the 6 months of weekly treatment |
preventing fungal infections after bone marrow transplant Good Evidence | Large; systemic fungal infections cut by roughly 60% to 80% | People undergoing bone marrow transplantation with chemotherapy or radiation | During the weeks of low blood counts after transplant |
preventing relapse of cryptococcal meningitis in AIDS Good Evidence | Large; relapse 2% versus 18% | People with AIDS who have completed initial treatment for cryptococcal meningitis | Over about 9 to 12 months of follow-up |
vaginal yeast infection (single dose)
- Effect
- Similar to 7 days of vaginal clotrimazole; about 3 in 4 clinically cured at 35 days
- Best fit
- Adults with an acute, uncomplicated vaginal yeast infection
- Time
- Assessed at 14 and 35 days
preventing recurrent vaginal yeast infections (maintenance)
- Effect
- Large during treatment (90.8% versus 35.9% disease-free at 6 months), smaller after stopping
- Best fit
- Women with recurrent vulvovaginal candidiasis
- Time
- During the 6 months of weekly treatment
preventing fungal infections after bone marrow transplant
- Effect
- Large; systemic fungal infections cut by roughly 60% to 80%
- Best fit
- People undergoing bone marrow transplantation with chemotherapy or radiation
- Time
- During the weeks of low blood counts after transplant
preventing relapse of cryptococcal meningitis in AIDS
- Effect
- Large; relapse 2% versus 18%
- Best fit
- People with AIDS who have completed initial treatment for cryptococcal meningitis
- Time
- Over about 9 to 12 months of follow-up
Evidence for 4 uses
AI-assisted evidence assessment. Talk to your doctor before relying on any single supplement.
vaginal yeast infection (single dose)
Disease adjunctA multicenter, single-blinded randomized trial compared one 150 mg oral dose of fluconazole with 7 days of clotrimazole 100 mg vaginal tablets in 429 patients with acute Candida vaginitis. There were no significant differences: at 14 days, 94% versus 97% were cured or improved, and at 35 days 75% of both groups remained clinically cured. People with a history of recurrent infection responded less well in both groups. Mild side effects were reported by 27% on fluconazole and 17% on clotrimazole.
Bottom line: One fluconazole tablet worked as well as a week of vaginal clotrimazole for acute vaginal yeast infection.
preventing recurrent vaginal yeast infections (maintenance)
Disease adjunctAfter three 150 mg doses to clear symptoms, 387 women with recurrent vulvovaginal candidiasis were randomly assigned to fluconazole 150 mg or placebo weekly for 6 months, then followed 6 more months without treatment. Disease-free rates were 90.8% versus 35.9% at 6 months, 73.2% versus 27.8% at 9 months and 42.9% versus 21.9% at 12 months. The median time to recurrence was 10.2 versus 4.0 months. The benefit faded after treatment stopped, and the authors note that a long-term cure remains difficult.
Bottom line: Weekly fluconazole kept most women free of recurrent yeast infections while they took it.
preventing fungal infections after bone marrow transplant
Disease adjunctTwo double-blind trials compared fluconazole 400 mg a day with placebo in bone marrow transplant recipients. In the first (356 patients), systemic fungal infections occurred in 2.8% versus 15.8%, and deaths attributed to systemic fungal infection were 1 versus 10, though overall mortality did not differ significantly. In the second (300 patients, treated through day 75), systemic fungal infections occurred in 7% versus 18%, and there were 31 versus 52 deaths up to day 110. In the first trial, fluconazole did not prevent infection with Candida krusei, and ALT rose more on fluconazole.
Bottom line: Daily fluconazole sharply reduced serious fungal infections in bone marrow transplant patients in two trials.
preventing relapse of cryptococcal meningitis in AIDS
Disease adjunctAfter first treatment with amphotericin B, 218 people with AIDS and cryptococcal meningitis were randomly assigned to oral fluconazole 200 mg a day or weekly intravenous amphotericin B. Among 189 evaluable patients followed a median 286 days, symptomatic relapse occurred in 2% on fluconazole versus 18% on amphotericin B; an estimated 97% versus 78% stayed relapse-free at one year. Serious drug toxicity and bacterial infections were more common with amphotericin B. The trial was done in the early 1990s, before modern HIV treatment.
Bottom line: Daily oral fluconazole prevented cryptococcal meningitis relapse far better than weekly intravenous amphotericin B.
How it works
How to take it
What to track
Bottom line: Your prescriber sets the dose; food does not matter, but tell everyone who prescribes for you that you are taking it, because its enzyme effect lasts 4 to 5 days after the last dose.
Safety
Know the common side effects, key cautions, and who should avoid it.
Common side effects
Serious risks
Rare serious liver injury, including fatal cases, mainly in people with serious underlying illness; it has usually but not always reversed after stopping.
QT prolongation and rare torsades de pointes, mostly in seriously ill people with other risk factors such as low potassium or advanced heart failure.
Serious skin reactions (exfoliative skin disorders), with fatal outcomes in people with serious underlying disease, and rare anaphylaxis.
Reversible low adrenal function (adrenal insufficiency) has been reported.
Harm to the unborn baby at high doses: case reports describe a distinct pattern of birth defects after 400 to 800 mg a day during most or all of the first trimester.
Raised levels of other drugs through enzyme inhibition that lasts 4 to 5 days after the last dose, including bleeding with warfarin and low blood sugar with sulfonylureas (one fatal case with glyburide).
Who should avoid it
- People with a past allergic reaction to fluconazole or its ingredients; caution with allergy to other azoles
- People taking erythromycin, pimozide or quinidine: contraindicated because of heart rhythm risk
- Pregnant people, except for severe or potentially life-threatening fungal infections where the benefit outweighs the possible risk
- People with hereditary fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase deficiency should not use the oral suspension, which contains sucrose
Pregnancy & breastfeeding
Pregnancy: the label says use in pregnancy should be avoided except for severe or potentially life-threatening fungal infections. Case reports link high doses (400 to 800 mg a day) during most or all of the first trimester with a distinct pattern of birth defects, and epidemiological studies suggest a possible risk of miscarriage and birth defects with 150 mg single or repeated doses in the first trimester, though these studies have limitations and the findings have not been confirmed. People who could become pregnant and take 400 to 800 mg a day should consider effective contraception during treatment and for about 1 week after the last dose. Breastfeeding: fluconazole passes into breast milk at low levels; after a single 150 mg dose, the estimated infant dose was about 13% of the pediatric treatment dose, and a survey of 96 breastfeeding women taking 150 mg every other day reported no serious reactions in infants. The label advises caution when a nursing woman takes it.
Interactions
The label contraindicates these with fluconazole because raised levels can prolong the QT interval and cause dangerous heart rhythms. Make sure every prescriber knows you are taking fluconazole.
Fluconazole slows CYP2C9, the main enzyme that clears warfarin. The label reports bruising, nosebleeds, gastrointestinal bleeding and blood in the urine with raised prothrombin times when the two were combined, and in a volunteer study one of 13 men had his prothrombin response double. Tell whoever manages your warfarin before starting even a single dose; they will usually check your INR more often, during and for several days after the course.
S. boulardii is a live yeast, so fluconazole would be expected to cancel its effect, though this has not been measured. The bigger issue is safety: in Finnish hospitals, at least 20 of 46 people with Saccharomyces bloodstream infection were taking an S. boulardii probiotic (odds ratio 14), and an intensive care outbreak was traced to it. Tell your prescriber if you use it; they can advise whether to pause it.
Fluconazole raised glipizide and glyburide exposure by 44% to 49% in volunteers, and the label reports clinically significant low blood sugar, including one death with glyburide. Your prescriber may adjust the diabetes dose and ask you to check your blood sugar more often.
The label says the risk of muscle injury and rhabdomyolysis rises when fluconazole is combined with these statins, and a statin dose reduction may be needed. Report unexplained muscle pain or weakness, and ask your prescriber how to handle your statin during the course.
Red yeast rice contains monacolin K, the same molecule as lovastatin, a statin cleared by CYP3A4. The label says the risk of muscle injury rises when fluconazole, a moderate CYP3A4 inhibitor, is combined with CYP3A4-cleared statins, and that its enzyme effect lasts 4 to 5 days after stopping. No study has tested fluconazole with red yeast rice, and a single dose for a yeast infection was not studied. Tell your prescriber or pharmacist if you take it, and report muscle pain or weakness.
Fluconazole is a moderate CYP3A4 inhibitor, and grapefruit juice lowers CYP3A4 in the gut wall for up to 24 hours. The pair has not been studied together, and fluconazole itself is over 90% absorbed, so grapefruit is unlikely to change fluconazole. The concern is a third medicine with a grapefruit warning, such as some statins or calcium channel blockers, which both could raise. Ask your pharmacist if you take one.
Documented interactions
Evidence-graded pair pages with sources, dosing notes, and timing guidance, a complement to the narrative section above.
Warnings (3)
+ warfarin
highFluconazole slows CYP2C9, the main enzyme that clears warfarin, and the Diflucan label reports bleeding events (bruising, nosebleeds, gastrointestinal bleeding, blood in the urine) with raised prothrombin times in people taking both. In 6 women on long-term warfarin, a single 150 mg dose raised the INR above 4 or caused bleeding that needed a warfarin dose reduction in half of them, and in a large Medicaid study recent fluconazole use was linked to about twice the odds of hospitalization for gastrointestinal bleeding.
+ red yeast rice
moderateFluconazole is a moderate inhibitor of CYP3A4, the enzyme that breaks down lovastatin, and red yeast rice contains monacolin K, the same molecule as lovastatin. The Diflucan label says the risk of myopathy and rhabdomyolysis rises when fluconazole is combined with statins cleared by CYP3A4, and asks for watching for muscle symptoms and checking creatine kinase if the combination is needed. No study or case report has tested fluconazole with red yeast rice or with lovastatin itself, and the lovastatin label does not list fluconazole, so this rests on the label's class warning and the shared enzyme.
+ grapefruit
lowFluconazole is a moderate inhibitor of CYP3A4, and grapefruit blocks CYP3A4 in the gut wall. Grapefruit is unlikely to change fluconazole itself: the Diflucan label says over 90 percent of an oral dose is absorbed, food does not affect exposure, and about 80 percent leaves the body unchanged in the urine. No study has tested the pair. The theoretical concern is a third medicine with its own grapefruit warning, whose levels both could raise.
Choosing a product
What to look for on the label, and what to be skeptical of.
Look for…
Be skeptical of…
Frequently asked questions
Can I eat grapefruit while taking fluconazole?⌄
Grapefruit is unlikely to change fluconazole itself, which is almost fully absorbed. The concern is another medicine you take that carries a grapefruit warning, such as some statins, because fluconazole and grapefruit both slow the same enzyme. Ask your pharmacist if you take one.
Should I stop my probiotic while I take fluconazole?⌄
Bacterial probiotics are not expected to be affected, because fluconazole targets a fungal membrane component that bacteria lack. Yeast probiotics (Saccharomyces boulardii) are a different matter: the drug would be expected to act on them, and they have caused rare bloodstream infections. Ask your prescriber about your product.
I take warfarin. Is a single fluconazole tablet a problem?⌄
It can be. The label reports bleeding when fluconazole and warfarin are combined, and the enzyme effect lasts 4 to 5 days after the last dose. Tell whoever manages your warfarin before you take it so they can plan INR checks.
Does fluconazole stop birth control pills from working?⌄
The label says studies at 50 to 200 mg a day found no drop in hormone levels; levels rose slightly. It concludes that multiple doses at these strengths are unlikely to affect a combined pill. Ask your pharmacist if you have questions about your specific product.
Can I take fluconazole if I am pregnant?⌄
The label says to avoid it in pregnancy except for severe or life-threatening fungal infections, because high doses have been linked to birth defects. Talk with your prescriber, who can suggest other treatments for a vaginal yeast infection.
References by claim
vaginal yeast infection (single dose)
Sobel et al., 1995 · PubMed (1995) link
preventing recurrent vaginal yeast infections (maintenance)
Sobel et al., 2004 · PubMed (2004) link
preventing fungal infections after bone marrow transplant
preventing relapse of cryptococcal meningitis in AIDS
Powderly et al., 1992 · PubMed (1992) link
Safety
Diflucan (fluconazole) tablets and oral suspension prescribing information · DailyMed (FDA label) link
Interaction: Grapefruit
Bailey et al., 1998 · PMC (1998) link
Interaction: Saccharomyces boulardii (yeast probiotic)
Interaction: Red yeast rice
Li et al., 2005 · PubMed (2005) link
Track Fluconazole with Pilora
Set up dose reminders, check interactions, and join the community in the Pilora app.
Disclaimer: This page summarizes published clinical-trial data for educational purposes and is not medical advice or a recommendation to use this prescription medication. Dosing, eligibility, and monitoring must be decided by a licensed prescriber.
